Episode Details
Back to Episodes
Breakthrough Research in Autoimmune Skin Treatment by Scinai Immunotherapeutics
Published 1 year, 1 month ago
Description
Scinai Immunotherapeutics, known for their breakthrough PC111 research, is advancing a non-immunosuppressive treatment for severe autoimmune skin conditions by blocking keratinocyte apoptosis. Dr. Roberta Lotti's work on the anti-Fas Ligand monoclonal antibody was recognized with the 'Oscar of Italian Dermatology'.